Whilst inter-donor variability meant Nalm6 killing at a 1:1 effector to target (E:T) ratio did not reach statistical significance, the oncolytic capacity of OMV-expanded cells was equivalent to that of cells activated with zoledronate.
← all excerpts
Bacterial outer-membrane vesicles promote Vγ9Vδ2 T cell oncolytic activity.
1
—
—